ArticleFrontiers in molecular biosciences2026
Carbon dots derived from
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As of now, effective clinical treatments for burn-induced intestinal injury are still limited. Carbon dots (CDs), recognized for their unique biological activities, present a promising avenue for the development of innovative nanomedicine-based therapies aimed at addressing intestinal barrier dysfunction following burns. Methods: This study reports the successful synthesis of a novel class of CDs-specifically derived from Results: Notably, SRC-CDs synthesized across a spectrum of pyrolysis temperatures (260 °C, 310 °C, 360 °C, and 410 °C) consistently exhibited particle diameters within a defined nanoscale range (2.0-8.0 nm) and featured a rich surface chemistry characterized by diverse functional groups, irrespective of the specific thermal conditions employed. Importantly, Conclusion: This study developed biocompatible SRC-CDs via green pyrolysis, demonstrating their efficacy in mitigating burn-induced intestinal injury. SRC-CDs enhanced barrier integrity, reduced inflammation and oxidative stress, with the 360 °C-synthesized variant showing optimal bioactivity, thereby supporting the traditional use of SR and proposing a novel nanomaterial strategy for managing critical burn complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.